Literature DB >> 8146325

Alterations in transcription factor binding in radioresistant human melanoma cells after ionizing radiation.

W M Sahijdak1, C R Yang, J S Zuckerman, M Meyers, D A Boothman.   

Abstract

We analyzed alterations in transcription factor binding to specific, known promoter DNA consensus sequences between irradiated and unirradiated radioresistant human melanoma (U1-Mel) cells. The goal of this study was to begin to investigate which transcription factors and DNA-binding sites are responsible for the induction of specific transcripts and proteins after ionizing radiation (Boothman et al., Proc. Natl. Acad. Sci. USA 90, 7200, 1993). Transcription factor binding was observed using DNA band-shift assays and oligonucleotide competition analyses. Confluence-arrested U1-Mel cells were irradiated (4.5 Gy) and harvested at 4 h. Double-stranded oligonucleotides containing known DNA-binding consensus sites for specific transcription factors were used. Increased DNA-binding activity after ionizing radiation was noted with oligonucleotides containing the CREB, NF-kappa B and Sp1 consensus sites. Increased DNA binding activity after ionizing radiation was noted with oligonucleotides containing the CREB, NF-kappa B and Sp1 consensus sites. No changes in protein binding to AP-1, AP-2, AP-3 or CTF/NF1, GRE or Oct-1 consensus sequences were noted. X-ray activation of select transcription factors, which bind certain consensus sites in promoters, may cause specific induction or repression of gene transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146325

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells.

Authors:  R L Meighan-Mantha; A T Riegel; S Suy; V Harris; F H Wang; C Lozano; T L Whiteside; U Kasid
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells.

Authors:  George P Amorino; Virginia M Hamilton; Kristoffer Valerie; Paul Dent; Guido Lammering; Rupert K Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

3.  Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage.

Authors:  Hui Yu
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

4.  Imaging of nuclear factor κB activation induced by ionizing radiation in human embryonic kidney (HEK) cells.

Authors:  Arif Ali Chishti; Christa Baumstark-Khan; Christine E Hellweg; Günther Reitz
Journal:  Radiat Environ Biophys       Date:  2014-06-01       Impact factor: 1.925

5.  Radiation-Triggered NF-κB Activation is Responsible for the Angiogenic Signaling Pathway and Neovascularization for Breast Cancer Cell Proliferation and Growth.

Authors:  Hui Yu; Sumathy Mohan; Mohan Natarajan
Journal:  Breast Cancer (Auckl)       Date:  2012-07-23

6.  NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.

Authors:  J E Hunter; E Willmore; J A E Irving; Z Hostomsky; S J Veuger; B W Durkacz
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

7.  Increased expression after X-irradiation of MUC1 in cultured human colon carcinoma HT-29 cells.

Authors:  Y Kang; K Hirano; N Suzuki; A Enomoto; A Morita; T Irimura; K Sakai
Journal:  Jpn J Cancer Res       Date:  2000-03

Review 8.  Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression.

Authors:  Yu Rou Puar; Muthu K Shanmugam; Lu Fan; Frank Arfuso; Gautam Sethi; Vinay Tergaonkar
Journal:  Biomedicines       Date:  2018-07-27

Review 9.  Transcription Factors in the Cellular Response to Charged Particle Exposure.

Authors:  Christine E Hellweg; Luis F Spitta; Bernd Henschenmacher; Sebastian Diegeler; Christa Baumstark-Khan
Journal:  Front Oncol       Date:  2016-03-21       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.